These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26883149)

  • 1. Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.
    Xiao X; Ni Y; Jia YM; Zheng M; Xu HF; Xu J; Liao C
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1508-1511. PubMed ID: 26883149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
    Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
    Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of N-phenylacetyl (sulfonyl) 4,5-dihydropyrazole derivatives as potential antitumor agents.
    Liu XH; Ruan BF; Liu JX; Song BA; Jing LH; Li J; Yang Y; Zhu HL; Qi XB
    Bioorg Med Chem Lett; 2011 May; 21(10):2916-20. PubMed ID: 21486698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo.
    Wang Y; Cheng FX; Yuan XL; Tang WJ; Shi JB; Liao CZ; Liu XH
    Eur J Med Chem; 2016 Apr; 112():231-251. PubMed ID: 26900656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
    Shi JB; Tang WJ; Qi XB; Li R; Liu XH
    Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel methodology for synthesis of dihydropyrazole derivatives as potential anticancer agents.
    Wang X; Pan YM; Huang XC; Mao ZY; Wang HS
    Org Biomol Chem; 2014 Apr; 12(13):2028-32. PubMed ID: 24519368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
    Sun J; Zhu H; Yang ZM; Zhu HL
    Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro.
    Chen X; Zha GF; Wang JQ; Liu XH
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1266-1270. PubMed ID: 30139286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo.
    Shi JB; Chen LZ; Wang Y; Xiou C; Tang WJ; Zhou HP; Liu XH; Yao QZ
    Eur J Med Chem; 2016 Nov; 124():729-739. PubMed ID: 27639364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.
    Liu XH; Li J; Wu FR; Song BA; Bhadury PS; Shi L
    Med Chem; 2011 Nov; 7(6):605-10. PubMed ID: 22313300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
    Wu XQ; Huang C; Jia YM; Song BA; Li J; Liu XH
    Eur J Med Chem; 2014 Mar; 74():717-25. PubMed ID: 24119869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation, 3D-QSAR studies of novel aryl-2H-pyrazole derivatives as telomerase inhibitors.
    Luo Y; Zhang S; Qiu KM; Liu ZJ; Yang YS; Fu J; Zhong WQ; Zhu HL
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1091-5. PubMed ID: 23312949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents.
    Huang XF; Lu X; Zhang Y; Song GQ; He QL; Li QS; Yang XH; Wei Y; Zhu HL
    Bioorg Med Chem; 2012 Aug; 20(16):4895-900. PubMed ID: 22819191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel dihydropyrazole-chromen: Design and modulates hTERT inhibition proliferation of MGC-803.
    Chen YY; Wu XQ; Tang WJ; Shi JB; Li J; Liu XH
    Eur J Med Chem; 2016 Mar; 110():65-75. PubMed ID: 26807545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticancer activity of some 8-substituted-7-methoxy-2H-chromen-2-one derivatives toward hepatocellular carcinoma HepG2 cells.
    Amin KM; Abou-Seri SM; Awadallah FM; Eissa AA; Hassan GS; Abdulla MM
    Eur J Med Chem; 2015 Jan; 90():221-31. PubMed ID: 25461322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents.
    Liu XH; Li J; Shi JB; Song BA; Qi XB
    Eur J Med Chem; 2012 May; 51():294-9. PubMed ID: 22405648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and molecular docking study of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential antitumor agents.
    Liu XH; Liu HF; Chen J; Yang Y; Song BA; Bai LS; Liu JX; Zhu HL; Qi XB
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5705-8. PubMed ID: 20800480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation, and molecular docking studies of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan moiety as potential anticancer agents.
    Zhang XM; Qiu M; Sun J; Zhang YB; Yang YS; Wang XL; Tang JF; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(21):6518-24. PubMed ID: 21962523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new chromen-4-one derivatives as telomerase inhibitors through regulating expression of dyskerin.
    Quan Wang J; Di Yang M; Chen X; Wang Y; Zeng Chen L; Cheng X; Hua Liu X
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1199-1211. PubMed ID: 30132373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.